...
首页> 外文期刊>Cytotherapy >MSCs can be differentially isolated from maternal, middle and fetal segments of the human umbilical cord
【24h】

MSCs can be differentially isolated from maternal, middle and fetal segments of the human umbilical cord

机译:MSC可以与人脐带的母体,中层和胎儿部分不同地分离

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Background aims. Human Wharton's jelly derived mesenchymal stromal cells (hWJMSCs) are possibly the most suitable allogeneic cell source for stromal cell therapy and tissue engineering applications because of their hypo-immunogenic and non-tumorigenic properties, easy availability and minimal ethical concerns. Furthermore, hWJMSCs possess unique properties of both adult mesenchymal stromal cells and embryonic stromal cells. The human umbilical cord (UC) is approximately 50-60 cm long and the existing studies in the literature have not provided information on which segment of the UC was studied. In this study, hWJMSCs derived from three anatomical segments of the UC are compared. Methods. Three segments of the whole UC, each 3 cm in length, were identified anatomically as the maternal, middle and fetal segments. The hWJMSCs from the different segments were analyzed via trypan blue exclusion assay to determine the growth kinetics and cell viability, flow cytometry for immunophenotyping and immunofluorescence and reverse transcriptase polymerase chain reaction (RT-PCR) for expression of stromal cell transcriptional factors. Furthermore, the trilineage differentiation potential (osteogenic, adipogenic and chondrogenic) of these cells was also assessed. Results. hWJMSCs isolated from the maternal and fetal segments displayed greater viability and possessed a significantly higher proliferation rate compared with cells from the middle segment. Immunophenotyping revealed that hWJMSCs derived from all three segments expressed the MSC markers CD105, CD73, CD90, CD44, CD13 and CD29, as well as HLA-ABC and HLA-DR, but were negative for hematopoietic markers CD14, CD34 and CD45. Analysis of the embryonic markers showed that all three segments expressed Nanog and Oct 3/4, but only the maternal and fetal segments expressed SSEA 4 and TRA-160. Cells from all three segments were able to differentiate into chondrogenic, osteogenic and adipogenic lineages with the middle segments showing much lower differentiation potential compared with the other two segments. Conclusions. hWJMSCs derived from the maternal and fetal segments of the UC are a good source of MSCs compared with cells from the middle segment because of their higher proliferation rate and viability. Fetal and maternal segments are the preferred cell source for bone regeneration.
机译:背景目标。沃顿氏胶冻来源的间充质基质细胞(hWJMSC)可能是基质细胞治疗和组织工程应用中最合适的同种异体细胞来源,因为它们具有低免疫原性和非致瘤性,易于获得且在伦理方面的关注极少。此外,hWJMSC具有成人间充质基质细胞和胚胎基质细胞的独特属性。人脐带(UC)大约50-60厘米长,文献中的现有研究尚未提供有关研究UC哪个部分的信息。在这项研究中,比较了来自UC的三个解剖部分的hWJMSC。方法。解剖学上将整个UC的三个部分(每个长度为3 cm)识别为母亲,中部和胎儿部分。通过台盼蓝排除法分析了来自不同区段的hWJMSC,以确定其生长动力学和细胞活力,流式细胞术进行免疫表型分析和免疫荧光分析,以及逆转录酶聚合酶链反应(RT-PCR)来表达基质细胞转录因子。此外,还评估了这些细胞的三系分化潜能(成骨,成脂和成软骨)。结果。与来自中间部分的细胞相比,从母体和胎儿部分分离出的hWJMSCs显示出更高的生存力,并具有更高的增殖率。免疫分型显示,来自所有三个区段的hWJMSC表达MSC标记CD105,CD73,CD90,CD44,CD13和CD29,以及HLA-ABC和HLA-DR,但对造血标记CD14,CD34和CD45呈阴性。胚胎标记物的分析表明,所有三个片段均表达Nanog和Oct 3/4,但只有母亲和胎儿片段均表达SSEA 4和TRA-160。来自所有三个区段的细胞能够分化为成软骨,成骨和成脂谱系,与其他两个区段相比,中间区段显示出低得多的分化潜力。结论与来自中间部分的细胞相比,源自UC母体和胎儿部分的hWJMSC是MSC的良好来源,因为它们具有更高的增殖率和活力。胎儿和母体节段是骨骼再生的首选细胞来源。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号